We present a case report of a 64-year-old male reported to have type 2 diabetes who developed euDKA while taking SGLT2 inhibitors, and was revealed to have latent autoimmune diabetes in adults (LADA). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.